Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ESO-Shanghai 15: Chemoradiotherapy vs Radiotherapy in Elderly ESCC
NCT04519905Phase 3Recruiting
- Sponsor
- Fudan University
- Start
- Jan 2020
- Primary completion
- Dec 2024
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 3 trial of paclitaxel, carboplatin in Esophageal Squamous Cell Carcinoma (ESCC), sponsored by Fudan University. Started Jan 2020; status: recruiting.
02
Drugs
paclitaxelcarboplatin
03
Conditions
Esophageal Squamous Cell Carcinoma (ESCC)
Beyond the preview
Go deeper on NCT04519905.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04519905.